Key result
Implantable cardioverter defibrillator use in patients with left ventricular assist devices requires a dedicated randomized trial, such as MADIT-VAD, to determine its clinical necessity.
Why the study?
Is there a need for an implantable cardioverter defibrillator in patients with left ventricular assist devices?
Is there a need for an implantable cardioverter defibrillator in patients with left ventricular assist devices?
This editorial proposes the need for a randomized trial (MADIT-VAD) to evaluate the benefit of ICDs in patients with LVADs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Valentina Kutyifa (2016) studied this question. Implantable cardioverter defibrillator use in patients with left ventricular assist devices requires a dedicated randomized trial, such as MADIT-VAD, to determine its clinical necessity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: